# OptimizeRx Corp: Form 8-K/A, filed Jan 5, 2024

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: 8-K/A
- Filed: 2024-01-05
- Accepted by EDGAR: Jan 5, 2024, 22:19 ET
- Period: 2023-10-20
- Accession: 0001213900-24-001616
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000121390024001616/ea191205-8ka1_optimizerx.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000121390024001616/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000121390024001616/ea191205-8ka1_optimizerx.htm

Filed Jan 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-001616. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.